¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"two phase sampling"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • apical two chamber view
    ½É÷2¹æµµ
  • area sampling
    Áö¿ªÃßÃâ(¹ý)
  • cluster sampling
    ¹«¸®ÃßÃâ(¹ý), ±ºÁýÃßÃâ(¹ý)
  • continuous interleaved sampling
    ¿¬¼Ó»ðÀÔÇ¥º»ÃßÃâ
  • chorionic villi sampling
    À¶¸ð¸·À¶¸ðÇ¥º»Ã¤Ãë
  • density sampling
    ¹ÐµµÇ¥º»ÃßÃâ(¹ý)
  • double sampling
    ÀÌÁßÇ¥º»ÃßÃâ(¹ý)
  • one stage sampling
    ÀϴܰèÇ¥º»ÃßÃâ(¹ý)
  • point sampling
    1. Á¡ÃßÃâ(¹ý) 2. Á¡Ç¥Áý
  • primary sampling unit
    ÀÏÂ÷ÃßÃâ´ÜÀ§
  • proportionate sampling
    ºñ·ÊÃßÃâ(¹ý)
  • percutaneous umbilical blood sampling
    ÇǺΰæÀ¯ÅÈÁÙÇ÷¾×äÃë(¹ý), °æÇÇÁ¦´ëÇ÷¾×äÃë(¹ý)
  • percutaneous venous catheter sampling
    ÇǺΰæÀ¯Á¤¸ÆÄ«Å×ÅÍÇ÷¾×äÃë(¹ý), °æÇÇÁ¤¸ÆÄ«Å×ÅÍÇ÷¾×äÃë(¹ý)
  • quota sampling
    ÇÒ´çÇ¥º»ÃßÃâ(¹ý)
  • random sampling
    ¹«ÀÛÀ§Ç¥º»ÃßÃâ(¹ý)
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • sampling
    Ç¥º»ÃßÃâ
  • random sampling
    ¹«ÀÛÀ§Ç¥º»ÃßÃâ
  • luteal phase endometrial biopsy
    Ȳü±âÀڱ󻸷»ý°Ë
  • phase contrast
    À§»ó´ëÁ¶
  • luteal phase defect
    Ȳü±â°á¼Õ
  • phase difference
    À§»óÂ÷
  • phase-contrast microscope
    À§»óÂ÷Çö¹Ì°æ
  • phase
    »ó, ±â, À§»ó
  • acceleration phase
    ÃËÁø±â, °¡¼Ó±â
  • active phase
    Ȱ¼º±â
  • latent phase
    ÀáÀç±â , Àẹ±â
  • plateau phase
    ÆíÆò±â, °íÁ¶±â
  • relaxation phase
    À̿ϱâ, À̿ϻó
  • resolution phase
    ÇØ¼Ò±â
  • resting phase
    È޽ıâ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • two stage sampling
    ÀÌ´ÜÇ¥º»ÃßÃâ¹ý
  • apical two chamber view
    ½ÉÀ峡µÎ¹æ´Ü¸éµµ
  • two-way catheter
    µÎ±æÄ«Å×ÅÍ
  • two point discrimination
    µÎÁ¡½Äº°
  • two-point gait
    µÎÁ¡º¸Çà
  • two hit hypothesis
    ÀÌŸ°¡¼³
  • two-slide method
    ÀÌÁß½½¶óÀ̵å¹ý
  • standard double two step test
    Ç¥ÁØÀÌÁßÀ̴ܰè°Ë»ç
  • two point threshold
    µÎÁ¡½Äº°¹®Åΰª, µÎÁ¡½Äº°¿ªÄ¡
  • two-tail test
    ¾çÃø°ËÁ¤
  • area sampling
    Áö¿ªÃßÃâ¹ý
  • sampling bias
    Ç¥º»ÃßÃâ¹ÙÀ̾
  • cluster sampling
    ¹«¸®ÃßÃâ¹ý
  • density sampling
    ¹ÐµµÇ¥º»ÃßÃâ
  • double sampling
    ÀÌÂ÷Ç¥º»ÃßÃâ, ÀÌÁßÇ¥º»(¹ý)
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • area sampling
    Áö¿ªÃßÃâ¹ý(̤Ëç̧̧ËÑ).
  • point sampling
    Á¡ÃßÃâ¹ý(ËøÌ§Ì§ËÑ).
  • primary sampling unit
    ÀÏÂ÷ÃßÃâ´ÜÀ§(ÊÙ̧̧ËÀËô).
  • random sampling
    ¹«ÀÛÀ§Ç¥º»ÃßÃâ(ÊÙ̧̧).
  • 3D phase contrast angiography
    3Â÷¿ø À§»ó ´ëÁ¶ Ç÷°üÁ¶¿µ¼ú
  • DNA synthetic phase
    DNA ÇÕ¼º±â
  • Go phase
    Go±â
  • accelerated death phase
    °¡¼Ó»ç¸ê±â(˧ËÛË×ËÎË»).
  • acceleration phase
    ÃËÁø±â, °¡¼Ó±â(Ê¥áÜÑ¢).
  • acute phase protein
    ±Þ¼ºº´±â´Ü¹éÁú
  • acute phase reactant
    ±Þ¼º±â ÀÛ¿ë¹°Áú
  • acute phase reaction
    ±Þ¼º±â¹ÝÀÀ(¡­Ñ¢Úãëë)
  • acute phase reactive protein
    ±Þ¼º±â ¹ÝÀÀ¼º ´Ü¹é.
  • acute phase serum
    ±Þ¼ºº´±âÇ÷û
  • acute phase substances
    ±Þ¼º±â ¹°Áú(ÐáàõÑ¢Úªòõ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • two phase sampling
    ÀÌ»óÃßÃâ¹ý(ËöË× Ì§Ì§ËÑ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • two stage sampling
    ÀÌ´ÜÇ¥º»ÃßÃâ¹ý(ËöËÀ̰ËÓ̧̧ËÑ).
  • area sampling
    Áö¿ªÃßÃâ¹ý(̤Ëç̧̧ËÑ).
  • double sampling
    ÀÌÂ÷Ç¥º»ÃßÃâ(Ëö̤̰ËÓ̧̧), ÀÌÁßÇ¥º»(¹ý).
  • one stage sampling
    ÀÏ´Ü(Ç¥º»)ÃßÃâ¹ý(ËöËÀ̰ËÓ̧̧ËÑ).
  • percutaneous umbilical blood sampling
    °æÇÇÁ¦´ëÇ÷¾×äÃë¹ý(Ìèù«ð°Óáúìäûóõö¢Ûö)
  • percutaneous venous catheter sampling
    °æÇÇÁ¤¸ÆµµÀÚÇ÷¾×äÃë¹ý(¡­ð¡ØæÓôí­úì äûóõö¢Ûö).
  • point sampling
    Á¡ÃßÃâ¹ý(ËøÌ§Ì§ËÑ).
  • primary sampling unit
    ÀÏÂ÷ÃßÃâ´ÜÀ§(ÊÙ̧̧ËÀËô).
  • proportionate sampling
    ºñ·ÊÃßÃâ¹ý(ËÓËç̧̧ËÑ).
  • random sampling
    ¹«ÀÛÀ§Ç¥º»ÃßÃâ(ÊÙ̧̧).
  • sampling frequency
    Ç¥º» Á֯ļö
  • single sampling
    ´ÜÀÏÇ¥º»ÃßÃâ(¹ý)(ËÀËö̰ËÓ̧̧ËÑ).
  • upstream sampling method
    »ó·ùäÇ÷¹ý(ß¾êüóõúìÛö).
  • water sampling point
    ä¼öÁ¡(óõâ©ïÇ).
  • luteal phase progestational phase
    Ȳ(»ö)ü±â
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Luteal phase [Progestational phase]
    Ȳ(»ö)ü±â
    [¿¾ ¿ë¾î] Ȳü±â
  • Leptotene phase
    °¡´Â¼¶À¯±â
    [¿¾ ¿ë¾î] ¼¼»ç±â
  • Phase of cornification
    °¢Áú±â
    [¿¾ ¿ë¾î] °¢ÁúÈ­±â
  • Diplotene phase
    °ã¼¶À¯±â
    [¿¾ ¿ë¾î] ¹è»ç±â
  • Pachytene phase
    ±½Àº¼¶À¯±â
    [¿¾ ¿ë¾î] ÈÄ»ç±â
  • Ovogenetic phase
    ³­Àڹ߻ý±â
    [¿¾ ¿ë¾î] ³­Àڹ߻ý±â
  • Follicular phase
    ³­Æ÷±â
    [¿¾ ¿ë¾î] ³­Æ÷±â
  • Bilateral phase
    ´ëαâ
    [¿¾ ¿ë¾î] ¾çÃø»ó
  • Phase of desquamation
    ¹Ú¸®±â
    [¿¾ ¿ë¾î] ¹Ú¸®±â
  • Phase of incornification
    ºñ°¢Áú±â
    [¿¾ ¿ë¾î] ºñ°¢ÁúÈ­±â
  • Unequal phase
    ºñ´ëαâ
    [¿¾ ¿ë¾î] ºÎµî»ó
  • Inactive phase
    ºñȰµ¿±â
    [¿¾ ¿ë¾î] ÈÞÁö±â
  • Lactiferous phase
    ¼öÀ¯±â
    [¿¾ ¿ë¾î] ¼öÀ¯±â
  • Synaptic phase
    ¿¬Á¢±â
    [¿¾ ¿ë¾î] ¿¬Á¢±â
  • Menstrual phase
    ¿ù°æ±â
    [¿¾ ¿ë¾î] ¿ù°æ±â
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • erythrocytic phase
    ÀûÇ÷±¸³»¹ßÀ°±â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • two-carbon fragment
    ÀÌź¼Ò(ì£÷©áÈ) Á¶°¢
  • two-dimensional chromatography
    ÀÌÂ÷¿ø(ì£ó­êª)Å©·Î¸¶Åä±×·¡ÇÇ
  • two-dimensional electrophoresis
    ÀÌÂ÷¿ø Àü±â¿µµ¿(ì£ó­êªï³Ñ¨ç¶ÔÑ)
  • two-factor cross
    ÀÌÀÎÀÚ ±³Â÷(ì£ì×í­Îßó©)
  • two-five A
    ¿À(çé)A ÀÌÁ¶(ì£ðÚ)
  • two-genes-one-polypeptide chain
    ÀÌÀ¯ÀüÀÚ(ì£ë¶îîí­)- ÀÏ(ìé)Æú¸®ÆéŸÀÌµå »ç½½
  • two-messenger hypothesis
    ÀÌ(ì£)Àü·É(îîÖµ)¼³(àã)
  • two out of three method
    »ïÁß ÅÃÀ̹ý(ß²ñé÷Éì£Ûö)
  • two-point cross
    ÀÌÁ¡±³Â÷(ì£ïÇÎßó©)
  • two-state model
    ¾ç»ó(å»ßÒ)¸ðµ¨
  • aqueous phase separator centrifugation
    ¾×»ó ºÐ¸®Ã¼ ¿ø½ÉºÐ¸® (äûßÒ ÝÂ×îô÷ êÀãýÝÂ×î)
  • carboxylation phase
    Ä«¸£º¹½ÇÈ­(ûù)±â(Ñ¢)
  • death phase
    »ç¸ê±â(ÞÝØþÑ¢)
  • decline phase
    "°¨Åð±â(Êõ÷ÜÑ¢), (ÔÒ) death phase"
  • effective lethal phase
    À¯È¿ Ä¡»ç±â(êóüùöÈÞÝÑ¢)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • random sampling
    ¹«ÀÛÀ§Ç¥º»ÃßÃâ
  • sampling
    Ç¥º»ÃßÃâ, ½Ã·áÀçÃë
  • sampling frequency
    Ç¥º»Á֯ļö
  • two chambered right ventricle
    ¿ì½É½Ç¾çºÐÁõ
  • two dimensional Fourier transform
    ÀÌÂ÷¿øÇ»¸®¾îº¯È¯
  • two filamensional echocardiography
    À̸鼺ÃÊÀ½ÆÄ¼ú
  • two lumen catheter
    2°­ Ä«Å×ÅÍ
  • 3D phase contrast angiography
    3Â÷¿øÀ§»ó´ëÁ¶ Ç÷°üÃÔ¿µ¼ú
  • arterial phase
    µ¿¸Æ±â
  • bulk phase model
    µ¢¾î¸®À§»ó¸ðÇü
  • equilibrium phase
    ÆòÇü±â
  • gradient induced phase shift effect
    °æ»çÀ¯µµ À§»óº¯À§È¿°ú
  • in phase
    µ¿À§»ó
  • in-phase image
    À§»ó³»¿µ»ó
  • intravoxel phase dispersion
    º¹¼¿³»À§»óÈ®»ê
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ILP inadequate luteal phase; insufficiency of luteal phase; interstitial laser photocoagulation; interst...
SPIA solid-phase immunoabsorption; solid-phase immunoassay
CVS   1) Cardio-Vascular System; ½ÉÀå Ç÷°ü°è
  2) Chronic Villi Sampling; À¶¸ð¸· äÃë...
CVS cardiovascular surgery; cardiovascular system; challenge virus strain; chorionic villi sampling; cle...
DSDDT double sampling dye dilution technique
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ATPS Aqueous two-phase system
Phase I phase
S phase synthesis phase
CVS Chorion villus sampling
CVS Chorionic Villi Sampling
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • two-phase color reaction
    µÎ °¡Áö »ö±ò ¹ÝÀÀ
  • area sampling
    Áö¿ª ÃßÃâ¹ý
  • double sampling
    ÀÌÂ÷ Ç¥º» ÃßÃâ
  • percutaneous venous catheter sampling
    °æÇÇ Á¤¸Æ µµÀÚ Ç÷¾× äÃë¹ý
  • sampling error
    Ç¥º» ¿ÀÂ÷
    Ç¥º» µ¥ÀÌŸ·ÎºÎÅÍ °è»êµÈ ¸ð¼ö ÃßÁ¤Ä¡¿Í ¸ð¼öÀÇ Â÷ÀÌ.
  • sampling inspection
    Ç¥º» ÃßÃâ °Ë»ç
  • sampling number
    Ç¥º» ÃßÃâ ¼ö
  • stratified sampling
    ÃæÈ­ ÃßÃâ¹ý
  • anterior two thirds
    Àü¹æ 2/3
  • apical two chamber view
    ½É÷ 2¹æ ´Ü¸éµµ
  • simultaneous two-jaw surgery
    ¾ç¾Ç µ¿½Ã À̵¿ ¼ö¼ú
  • two dimensional Fourier transform
    ÀÌÂ÷¿ø Ç»¸®¾î º¯È¯
  • two lumen catheter
    2°­ Ä«Å×ÅÍ
  • two piece crown
    ºÀ¼º ±Ý°ü
  • two-point discrimination testing
    µÎ Á¡ ½Äº°´É °Ë»ç
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
biological sampling Denotes sampling that can be taken without jeopardy to the whole organism (e.g., for haematological or biochemical study). Because of the complexity of biological samples it is usually supposed that the source of the sample is thoroughly mixed and hence representative; this assumption is often not true e.g., in genetic studies in mosaic patients.
(05 Mar 2000)
random sampling A selection of elements by a formal randomizing device for purposes of inference about a population of inference from that population in such a way that the probability of each possible outcome may be precisely specified in advance; the inferences are necessarily stochastic.
(05 Mar 2000)
percutaneous umbilical blood sampling See: PUBS.
(12 Dec 1998)
chemical sampling A sample that is obtained by whatever means is convenient and then purified of irrelevant elements before analysis; the assumption of thorough mixing is not necessary.
(05 Mar 2000)
petrosal sinus sampling Sampling of blood levels of the adrenocorticotropic hormone (acth) by withdrawal of blood from the inferior petrosal sinus. The inferior petrosal sinus arises from the cavernous sinus and runs to the internal jugular vein. Sampling of blood at this level is a valuable tool in the differential diagnosis of cushing disease, cushing syndrome, and other adrenocortical diseases.
(12 Dec 1998)
chorionic villi sampling A method for diagnosis of foetal diseases by sampling the cells of the placental chorionic villi for DNA analysis, presence of bacteria, concentration of metabolites, etc. The advantage over amniocentesis is that the procedure can be carried out in the first trimester.
(12 Dec 1998)
chorionic villus sampling <procedure> A procedure for obtaining a sample of chorionic villi for the purpose of genetic testing, usually performed between 9 and 12th weeks of pregnancy.
Amniocentesis testing has greatly supplanted the use of this form of genetic testing.
(27 Sep 1997)
haphazard sampling The assembly of data in an unprescribed and undefined fashion that allows no sound scientific inferences other than establishing the existence of types. (Finding even one unicorn in such a set would establish that unicorns can exist, but no inference about their prevalence could be made from it.) Cf.: random sample.
(05 Mar 2000)
sampling The policy of inferring the behaviour of a whole batch by studying a fraction of it.
Origin: MF essample, from L. Exemplum, taking out
(05 Mar 2000)
sampling studies Studies in which a number of subjects are selected from all subjects in a defined population. Conclusions based on sample results may be attributed only to the population sampled.
(12 Dec 1998)
snowball sampling A method whereby interview subjects for a statistical study are obtained from subjects already interviewed for that study.This technique is most often used with target populations made up of elusive or uncooperative subjects (e.g., IV drug users). Those subjects first contacted are asked to name acquaintances, who are then approached, interviewed, and asked for additional names. In this way, a sufficient number of subjects can be accumulated to give a study adequate power.
(05 Mar 2000)
bufadienolides (two double bonds) Bufatrienolides (three double bonds), etc; they have varying numbers of hydroxyl groups at positions 3, 5, 14, and 16, and these may be further substituted. For structure, see steroids.
(05 Mar 2000)
gel diffusion precipitin tests in two dimensions Precipitin test's made in a layer of agar that permits radial diffusion, in both of the horizontal dimensions, of one or both reactants. Double (gel) diffusion in two dimensions (Ouchterlony test, technique, or method) incorporates antigen and antibody solutions placed in separate wells in a sheet of plain agar, permitting radial diffusion of both reactants; this method is widely used to determine antigenic relationships; the bands of precipitate that form where the reactants meet in optimal concentration are of three patterns, referred to as reaction of identity, reaction of partial identity (cross-reaction), and reaction of nonidentity.
(05 Mar 2000)
Master's two-step exercise test An early and long-used exercise challenge to identify ischemic heart disease using a pair of nine inch steps with a platform on top, the number of trips by the patient arbitrarily chosen and related to age and body weight.
See: two-step exercise test.
Synonym: Master's two-step exercise test.
(05 Mar 2000)
immunoelectrophoresis, two-dimensional Immunoelectrophoresis in which a second electrophoretic transport is performed on the initially separated antigen fragments into an antibody-containing medium in a direction perpendicular to the first electrophoresis.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • random sampling
    ÀÓÀÇ(¹«ÀÛÀ§)(Ç¥º»)ÃßÃâ¹ý !
  • sampling
    °ßº» ÃßÃâ;ramdom ~ ¹«ÀÛÀ§ ÃßÃâ¹ý
  • two
    µÑ
  • two-line
    ¹èÇüÀÇ
  • two-lined
    ¹èÇüÀÇ
  • two-tone
    ÅõÅæ Ä®·¯ÀÇ
  • two-toned
    ÅõÅæ Ä®·¯ÀÇ
  • color phase
    À¯Àü¿¡ ÀÇÇÑ Ã¼»ö º¯È­;°èÀý¿¡ µû¸¥ ¸ðÀÇÀÇ º¯È­»ö
  • number two
    Á¦ 2ÀÎÀÚ º¸Á¿ª;¶Ë;´ëº¯
  • phase
    º¯È­;¹ß´ÞÀÇ ´Ü°è;Çü¼¼;±¹¸é;¸é;»ó;À§»óÀ¸·Î ³ª´©´Ù
  • phase angle
    À§»ó°¢
  • phase contrast
    À§»óÂ÷
  • phase microscope
    À§»óÂ÷ Çö¹Ì°æ
  • phase modulation
    À§»ó º¯Á¶
  • phase zero
    (°èȹ µîÀÇ) Áغñ ´Ü°è;Á¦·Î ´Ü°è
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á